checkAd
    Startseite > Aktien > Biodesix > Nachrichten
    Biodesix Aktie
    1,5750
     
    USD
    +0,96 %
    +0,0150 USD
    Letzter Kurs 18.05.24 Nasdaq
    1,5700
     
    USD
    1.200 STK
    Geldkurs 17.05.24
    1,5800
     
    USD
    2.500 STK
    Briefkurs 17.05.24
    ISIN: US09075X1081 · WKN: A2QFCN · SYM: BDSX · USA

    Neueste Nachrichten

    Biodesix Announces First Quarter 2024 Results Driven by Growth in Lung Diagnostic Testing for Lung Nodule Management
    08.05.24 · Business Wire (engl.) · Biodesix
    Biodesix to Participate in the 2024 RBCCM Global Healthcare Conference
    07.05.24 · Business Wire (engl.) · Biodesix
    Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024
    24.04.24 · Business Wire (engl.) · Biodesix
    Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting
    09.04.24 · Business Wire (engl.) · Biodesix
    Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement
    05.04.24 · Business Wire (engl.) · Biodesix
    Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center
    25.03.24 · Business Wire (engl.) · Biodesix
    Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights
    01.03.24 · Business Wire (engl.) · Biodesix
    Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference
    26.02.24 · Business Wire (engl.) · Biodesix
    Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024
    16.02.24 · Business Wire (engl.) · Biodesix
    Biodesix Enhances Access to Nodify Lung Testing with Launch of New Blood Draw Method
    14.11.23 · Business Wire (engl.) · Biodesix
    Biodesix to Participate in Two Upcoming Investor Conferences in November
    09.11.23 · Business Wire (engl.) · Biodesix
     Biodesix Announces Third Quarter 2023 Results and Highlights
    07.11.23 · Business Wire (engl.) · Biodesix